Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 94
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Toxicol Sci ; 195(2): 213-230, 2023 09 28.
Artículo en Inglés | MEDLINE | ID: mdl-37498623

RESUMEN

Inhalation is a major route by which human exposure to substances can occur. Resources have therefore been dedicated to optimize human-relevant in vitro approaches that can accurately and efficiently predict the toxicity of inhaled chemicals for robust risk assessment and management. In this study-the IN vitro Systems to PredIct REspiratory toxicity Initiative-2 cell-based systems were used to predict the ability of chemicals to cause portal-of-entry effects on the human respiratory tract. A human bronchial epithelial cell line (BEAS-2B) and a reconstructed human tissue model (MucilAir, Epithelix) were exposed to triethoxysilane (TES) and trimethoxysilane (TMS) as vapor (mixed with N2 gas) at the air-liquid interface. Cell viability, cytotoxicity, and secretion of inflammatory markers were assessed in both cell systems and, for MucilAir tissues, morphology, barrier integrity, cilia beating frequency, and recovery after 7 days were also examined. The results show that both cell systems provide valuable information; the BEAS-2B cells were more sensitive in terms of cell viability and inflammatory markers, whereas MucilAir tissues allowed for the assessment of additional cellular effects and time points. As a proof of concept, the data were also used to calculate human equivalent concentrations. As expected, based on chemical properties and existing data, the silanes demonstrated toxicity in both systems with TMS being generally more toxic than TES. Overall, the results demonstrate that these in vitro test systems can provide valuable information relevant to predicting the likelihood of toxicity following inhalation exposure to chemicals in humans.


Asunto(s)
Células Epiteliales , Silanos , Humanos , Silanos/toxicidad , Silanos/metabolismo , Línea Celular , Bronquios
2.
Toxicology ; 465: 153060, 2022 01 15.
Artículo en Inglés | MEDLINE | ID: mdl-34871708

RESUMEN

With the increasing application of cell culture models as primary tools for predicting chemical safety, the quantitative extrapolation of the effective dose from in vitro to in vivo (QIVIVE) is of increasing importance. For developmental toxicity this requires scaling the in vitro observed dose-response characteristics to in vivo fetal exposure, while integrating maternal in vivo kinetics during pregnancy, in particular transplacental transfer. Here the transfer of substances across the placental barrier, has been studied using the in vitro BeWo cell assay and six embryotoxic compounds of different kinetic complexity. The BeWo assay results were incorporated in an existing generic Physiologically Based Kinetic (PBK) model which for this purpose was extended with rat pregnancy. Finally, as a "proof of principle", the BeWo PBK model was used to perform a QIVIVE based on developmental toxicity as observed in various different in vitro toxicity assays. The BeWo results illustrated different transport profiles of the chemicals across the BeWo monolayer, allocating the substances into two distinct groups: the 'quickly-transported' and the 'slowly-transported'. BeWo PBK exposure simulations during gestation were compared to experimentally measured maternal blood and fetal concentrations and a reverse dosimetry approach was applied to translate in vitro observed embryotoxicity into equivalent in vivo dose-response curves. This approach allowed for a direct comparison of the in vitro dose-response characteristics as observed in the Whole Embryo Culture (WEC), and the Embryonic Stem Cell test (cardiac:ESTc and neural:ESTn) with in vivo rat developmental toxicity data. Overall, the in vitro to in vivo comparisons suggest a promising future for the application of such QIVIVE methodologies for screening and prioritization purposes of developmental toxicants. Nevertheless, the clear need for further improvements is acknowledged for a wider application of the approach in chemical safety assessment.


Asunto(s)
Intercambio Materno-Fetal , Modelos Biológicos , Pruebas de Toxicidad , Trofoblastos/efectos de los fármacos , Animales , Transporte Biológico , Biomarcadores/sangre , Caproatos/toxicidad , Línea Celular , Relación Dosis-Respuesta a Droga , Femenino , Sangre Fetal/metabolismo , Edad Gestacional , Glicolatos/toxicidad , Humanos , Miconazol/toxicidad , Permeabilidad , Ácidos Ftálicos/toxicidad , Embarazo , Prueba de Estudio Conceptual , Ratas , Reproducibilidad de los Resultados , Medición de Riesgo , Silanos/toxicidad , Toxicocinética , Triazoles/toxicidad , Trofoblastos/metabolismo , Trofoblastos/patología , Ácido Valproico/toxicidad
3.
Pestic Biochem Physiol ; 180: 104998, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34955182

RESUMEN

Flusilazole (C16H15F2N3Si) is a triazole fungicide and it is being used widely in recent years to control fungal infections in various fruits and vegetables. This study aims to evaluate the impact of flusilazole on cytotoxicity, ATP-dependent cassette transporter proteins (ABC transporter proteins) in SerW3 cells. In this study, SerW3 cells have administrated with 25, 100, and 200 µM flusilazole, cell viability was performed. The quantity of the cellular lipids was evaluated spectrophotometrically. Moreover, the expression of the ABCA1 and ABCB1 proteins determined by immunofluorescence microscopy. Furtherly, evaluation of the cell death type and measurement of the activity of the antioxidant enzymes was performed. According to the results, flusilazole treatment gave rise to inhibition in cell viability, increase in apoptotic cell number, reduction in cellular lipids, and inhibition in the expression of ABCA1 and ABCB1 proteins. Furthermore, it caused decreases in antioxidant enzyme activities. It may be concluded that flusilazole administration may cause infertility/subfertility. The mechanism of action can be due to cytotoxicity, impairment of the detoxification mechanisms, lipid metabolism, and dysregulation of cell functions.


Asunto(s)
Metabolismo de los Lípidos , Estrés Oxidativo , Silanos , Triazoles , Animales , Línea Celular , Ratas , Silanos/toxicidad , Triazoles/toxicidad
4.
ACS Appl Mater Interfaces ; 13(39): 46938-46950, 2021 Oct 06.
Artículo en Inglés | MEDLINE | ID: mdl-34559507

RESUMEN

Smart response hydrogel has a broad application prospect in human health real-time monitoring due to its responses to a variety of stimuli. In this study, we developed a novel smart hydrogel dressing based on conductive MXene nanosheets and a temperature-sensitive PNIPAm polymer. γ-Methacryloxypropyltrimethoxysilane (KH570) was selected to functionalize the surface of MXene further to improve the interface compatibility between MXene and PNIPAm. Our prepared K-M/PNIPAm hydrogel was found to have a strain-sensitive property, as well as a respond to NIR phase change and volume change. When applied as a strain flexible sensor, this K-M/PNIPAm hydrogel exhibited a high strain sensitivity with a gauge factor (GF) of 4.491, a broad working strain range of ≈250%, a fast response of ∼160 ms, and good cycle stability (i.e., 3000 s at 20% strain). Besides, this K-M/PNIPAm hydrogel can be used as an efficient NIR light-controlled drug release carrier to achieve on-demand drug release. This work paved the way for the application of smart response hydrogel in human health real-time monitoring and NIR-controlled drug release functions.


Asunto(s)
Portadores de Fármacos/química , Hidrogeles/química , Materiales Inteligentes/química , Resinas Acrílicas/química , Resinas Acrílicas/farmacología , Resinas Acrílicas/efectos de la radiación , Resinas Acrílicas/toxicidad , Animales , Línea Celular , Portadores de Fármacos/farmacología , Portadores de Fármacos/efectos de la radiación , Portadores de Fármacos/toxicidad , Liberación de Fármacos/efectos de la radiación , Elasticidad , Hidrogeles/farmacología , Hidrogeles/efectos de la radiación , Hidrogeles/toxicidad , Rayos Infrarrojos , Masculino , Metacrilatos/química , Metacrilatos/farmacología , Metacrilatos/efectos de la radiación , Metacrilatos/toxicidad , Ratones , Ratas Sprague-Dawley , Silanos/química , Silanos/farmacología , Silanos/efectos de la radiación , Silanos/toxicidad , Piel/efectos de los fármacos , Materiales Inteligentes/farmacología , Materiales Inteligentes/efectos de la radiación , Materiales Inteligentes/toxicidad , Estrés Mecánico , Tetraciclina/química , Titanio/química , Titanio/farmacología , Titanio/efectos de la radiación , Titanio/toxicidad , Cicatrización de Heridas/efectos de los fármacos
5.
J Nanosci Nanotechnol ; 21(11): 5688-5693, 2021 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-33980381

RESUMEN

Even with all the recent technological improvements, cancer remains to be the disease with the highest impact on global health. Due to obviously disadvantages or limitations on traditional therapy, researchers are engaged to search for safely and effective methods in cancers' therapy. Photothermal therapy (PTT) has been employed in treating cancers and several of other diseases. In this study, novel thermosensitive and targeting nanoparticle, C225-silane-F127/gold nanorod (C-SFGR) combined with PTT was investigated in EGFR-overexpressing xenografts mice model. For better light to heat transformation exposed with 808 nm near-infrared (NIR) laser, the diameter of thermosensitive C-SFGR was designed at about 120 nm. To address the biocompatibility, the viability of A549 cell line was greater than 80% under high concentrations of C-SFGR (1,000 µg/mL), indicating its low cytotoxicity. After intravenous injection of C-SFGR and combined with NIR treatment for 2 min in A549 bearing mice, tumors were almost completely shriveled after 2 weeks. For developing as theranostic agent, C-SFGR was then labeled with 67Ga, with radiochemical purity over 98%. These present results suggest that C-SFGR could be also applied as a SPECT-imaging agent and as an effective antitumor agent.


Asunto(s)
Hipertermia Inducida , Nanotubos , Animales , Línea Celular Tumoral , Oro , Ratones , Fototerapia , Terapia Fototérmica , Polietilenos , Polipropilenos , Silanos/toxicidad
6.
ACS Appl Bio Mater ; 4(2): 1350-1359, 2021 02 15.
Artículo en Inglés | MEDLINE | ID: mdl-35014486

RESUMEN

This work reports the formation of spherical solid silica-encapsulated liposome particles (SLPs) as functions of the concentration of silica precursor, reaction time, temperature, and volume ratios of solvent, respectively. The solid SLPs are more robust and have better drug-loading-efficiency liquid liposomes in carrier formulations. The liquid-state liposomes are hard to handle and have a lower drug-loading efficiency because they are fragile to external stimuli and have narrow hydrophobic phospholipid bilayers. The SLPs were obtained by silicification with tetraethyl orthosilicate (TEOS) in the hydrophilic region of phospholipid bilayers by a sol-gel process. These SLPs were characterized by scanning electron microscopy (SEM), focused ion beam (FIB)-SEM, confocal laser scanning microscopy (CLSM), thermogravimetric analysis (TGA), ζ-potential, X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, and UV-vis spectroscopy. The obtained SLPs were spherical with an average size of 2-3 µm. The hydrophilic region of the SLP phospholipid bilayers was confirmed using CLSM with green fluorescent fluorescein isothiocyanate (FITC) labeling and FIB-SEM. Furthermore, the drug-loading capacity and in vitro cytotoxicity assessments were performed using several drug compounds and L929 cells. The drug-loading capacity of the SLPs was >95%, and in particular, the hydrophobic drug-loading capacity was 2.3 times higher than that of general liposomes. Moreover, the result of an in vitro cytotoxicity assessment of the SLPs was good, about 99% of cell viability.


Asunto(s)
Supervivencia Celular/efectos de los fármacos , Liposomas/química , Silanos/química , Silanos/toxicidad , Sistemas de Liberación de Medicamentos , Etanol , Microscopía Confocal , Microscopía Electrónica de Rastreo , Temperatura , Factores de Tiempo , Agua
7.
Mater Sci Eng C Mater Biol Appl ; 110: 110647, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32204077

RESUMEN

Evaluation of the biological properties of silanized graphene oxide is important in the context of biomedical applications of the material. In this study, we have evaluated the toxicity, immunogenicity and other biological properties like osteogenicity of silanized graphene oxide (SiGO). Graphene oxide (GO) was silanized using a common silanizing agent namely (3-aminopropyl) triethoxysilane (APTES). Silanization was confirmed through infrared spectroscopy and elemental mapping. Post-silanization, we did not observe any significant changes in the morphology of GO. Silanization leads to an increase in the interlayer distance and disorder in the lattice. Study of in vitro toxicity of SiGO on three different cell lines namely primary human dermal fibroblast, murine embryonic fibroblast and human osteosarcoma cell lines revealed that toxicity of SiGO was significantly less than GO. We further showed that in vitro immune activation of macrophage was less in the case of SiGO in comparison to GO. Profiling of osteogenic differentiation of human mesenchymal stem cell revealed that SiGO is less osteogenic than GO. Study of acute toxicity in the murine model indicated that GO was hepatotoxic at experimental concentration whereas SiGO did not show any significant toxicity. This study implied that SiGO is a better biocompatible material than GO.


Asunto(s)
Materiales Biocompatibles/farmacología , Grafito/farmacología , Silanos/farmacología , Adulto , Fosfatasa Alcalina/metabolismo , Animales , Recuento de Células Sanguíneas , Peso Corporal/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Dermis/citología , Fibroblastos/efectos de los fármacos , Grafito/toxicidad , Hemoglobinas/metabolismo , Humanos , Ratones , Células 3T3 NIH , Tamaño de los Órganos/efectos de los fármacos , Osteocalcina/metabolismo , Osteogénesis/efectos de los fármacos , Silanos/toxicidad , Espectrometría por Rayos X , Espectroscopía Infrarroja por Transformada de Fourier , Espectrometría Raman , Pruebas de Toxicidad , Difracción de Rayos X
8.
Chem Res Toxicol ; 33(3): 834-848, 2020 03 16.
Artículo en Inglés | MEDLINE | ID: mdl-32041405

RESUMEN

The ongoing developments in chemical risk assessment have led to new concepts building on integration of sophisticated nonanimal models for hazard characterization. Here we explore a pragmatic approach for implementing such concepts, using a case study of three triazole fungicides, namely, flusilazole, propiconazole, and cyproconazole. The strategy applied starts with evaluating the overall level of concern by comparing exposure estimates to toxicological potential, followed by a combination of in silico tools and literature-derived high-throughput screening assays and computational elaborations to obtain insight into potential toxicological mechanisms and targets in the organism. Additionally, some targeted in vitro tests were evaluated for their utility to confirm suspected mechanisms of toxicity and to generate points of departure. Toxicological mechanisms instead of the current "end point-by-end point" approach should guide the selection of methods and assays that constitute a toolbox for next-generation risk assessment. Comparison of the obtained in silico and in vitro results with data from traditional in vivo testing revealed that, overall, nonanimal methods for hazard identification can produce adequate qualitative hazard information for risk assessment. Follow-up studies are needed to further refine the proposed approach, including the composition of the toolbox, toxicokinetics models, and models for exposure assessment.


Asunto(s)
Fungicidas Industriales/toxicidad , Ensayos Analíticos de Alto Rendimiento , Silanos/toxicidad , Pruebas de Toxicidad , Triazoles/toxicidad , Humanos , Estructura Molecular , Medición de Riesgo
9.
Food Chem Toxicol ; 137: 111117, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31927004

RESUMEN

A challenge in cumulative risk assessment is to model hazard of mixtures. EFSA proposed to only combine chemicals linked to a defined endpoint, in so-called cumulative assessment groups, and use the dose-addition model as a default to predict combined effects. We investigated the effect of binary mixtures of compounds known to cause craniofacial malformations, by assessing the effect in the head skeleton (M-PQ angle) in 120hpf zebrafish embryos. We combined chemicals with similar mode of action (MOA), i.e. the triazoles cyproconazole, triadimefon and flusilazole; next, reference compounds cyproconazole or triadimefon were combined with dissimilar acting compounds, TCDD, thiram, VPA, prochloraz, fenpropimorph, PFOS, or endosulfan. These mixtures were designed as (near) equipotent combinations of the contributing compounds, in a range of cumulative concentrations. Dose-addition was assessed by evaluation of the overlap of responses of each of the 14 tested binary mixtures with those of the single compounds. All 10 test compounds induced an increase of the M-PQ angle, with varying potency and specificity. Mixture responses as predicted by dose-addition did not deviate from the observed responses, supporting dose-addition as a valid assumption for mixture risk assessment. Importantly, dose-addition was found irrespective of MOA of contributing chemicals.


Asunto(s)
Anomalías Craneofaciales/veterinaria , Enfermedades de los Peces/etiología , Silanos/toxicidad , Triazoles/toxicidad , Pez Cebra/embriología , Animales , Anomalías Craneofaciales/embriología , Anomalías Craneofaciales/etiología , Enfermedades de los Peces/embriología , Pez Cebra/anomalías , Pez Cebra/genética
10.
Eur J Pharm Sci ; 143: 105184, 2020 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-31846695

RESUMEN

The present study describes synthesis of amino-decorated mesoporous silica nanoparticles (MSNs) for sustained delivery and enhanced bioavailability of sofosbuvir. Sofosbuvir is active against hepatitis C virus and pharmaceutically classified as class III drug according to biopharmaceutics classification system (BCS). MSNs were synthesized using modified sol-gel method and the surface was decorated with amino functionalization. Drug loaded MSNs were also grafted with polyvinyl alcohol in order to compare it with the amino-decorated MSNs for sustained drug release. The prepared MSNs were extensively characterized and the optimized formulation was toxicologically and pharmacokinetically evaluated. The functionalized MSNs of 196 nm size entrapped 29.13% sofosbuvir in the pores, which was also confirmed by the decrease in surface area, pore volume and pore size. The drug-loaded amino-decorated MSNs revealed an improved thermal stability as confirmed by thermal analysis. Amino-decorated MSNs exhibited Fickian diffusion controlled sofosbuvir release as compared with non-functionalized and PVA grafted MSNs. Amino-decorated MSNs were deemed safe to use in Sprague-Dawley rats after 14-days exposure as confirmed by the toxicological studies. More interestingly, we achieved a 2-fold higher bioavailability of sofosbuvir in Sprague-Dawley rats in comparison with sofosbuvir alone, and the Tmax was delayed 3-times indicating a sustained release of sofosbuvir.


Asunto(s)
Antivirales , Portadores de Fármacos , Nanopartículas , Propilaminas , Silanos , Dióxido de Silicio , Sofosbuvir , Animales , Antivirales/administración & dosificación , Antivirales/química , Antivirales/farmacocinética , Antivirales/toxicidad , Supervivencia Celular/efectos de los fármacos , Preparaciones de Acción Retardada/administración & dosificación , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacocinética , Preparaciones de Acción Retardada/toxicidad , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/toxicidad , Liberación de Fármacos , Células Hep G2 , Humanos , Masculino , Nanopartículas/administración & dosificación , Nanopartículas/química , Nanopartículas/toxicidad , Alcohol Polivinílico/química , Porosidad , Propilaminas/administración & dosificación , Propilaminas/química , Propilaminas/farmacocinética , Propilaminas/toxicidad , Ratas Sprague-Dawley , Silanos/administración & dosificación , Silanos/química , Silanos/farmacocinética , Silanos/toxicidad , Dióxido de Silicio/administración & dosificación , Dióxido de Silicio/química , Dióxido de Silicio/toxicidad , Sofosbuvir/administración & dosificación , Sofosbuvir/química , Sofosbuvir/farmacocinética , Sofosbuvir/toxicidad
11.
Int J Pharm ; 573: 118867, 2020 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-31765788

RESUMEN

Heterofunctionalized gold nanoparticles (AuNPs) were obtained in a one pot reaction of gold precursor with cationic carbosilane dendrons (first to third generations, 1-3G) and (polyethylene)glycol (PEG) ligands in the presence of a reducing agent. The final dendron/PEG proportion on AuNPs depends on the initial dendron/PEG ratio (3/1, 1/1, 1/3) and dendron generation. AuNPs were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), ultraviolet spectroscopy (UV-VIS), thermogravimetric analysis (TGA), nuclear magnetic resonance (1H NMR) and zeta potential (ZP). Several assays have been carried out to determine the relevance of PEG/dendron ratio and dendron generation in the biomedical properties of PEGylated AuNPs and the results have been compared with those obtained for non-PEGylated AuNPs. Finally, analyses of PEG recognition by anti-PEG antibodies were carried out. In general, haemolysis, platelet aggregation and toxicity were reduced after PEGylation of AuNPs, the effect being dependent on dendron generation and dendron/PEG ratio. Dendron generation determines the exposure of PEG ligand and the interaction of this ligand with AuNPs environment. On the other hand, increasing PEG proportion diminishes toxicity but also favors interaction with antibodies.


Asunto(s)
Dendrímeros/toxicidad , Portadores de Fármacos/toxicidad , Oro/toxicidad , Nanopartículas del Metal/toxicidad , Silanos/toxicidad , Cationes/química , Supervivencia Celular/efectos de los fármacos , Técnicas de Química Sintética/métodos , Química Farmacéutica/métodos , Dendrímeros/química , Portadores de Fármacos/química , Dispersión Dinámica de Luz , Eritrocitos/efectos de los fármacos , Oro/química , Células HeLa , Humanos , Leucocitos Mononucleares , Espectroscopía de Resonancia Magnética , Nanopartículas del Metal/química , Nanopartículas del Metal/ultraestructura , Microscopía Electrónica de Transmisión , Agregación Plaquetaria/efectos de los fármacos , Polietilenglicoles/química , Silanos/química , Pruebas de Toxicidad
12.
Future Med Chem ; 11(23): 3005-3013, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31710246

RESUMEN

Aim: To research the synergistic activity of G2-S16 dendrimer and dapivirine (DPV) antiretroviral as microbicide candidate to prevent HIV-1 infection. Materials & methods: We assess the toxicity of DPV on cell lines by MTT assay, the anti-HIV-1 activity of G2-S16 and DPV alone or combined at several fixed ratios. Finally, their ability to inhibit the bacterial growth in vitro was assayed. The analysis of combinatorial effects and the effective concentrations were performed with CalcuSyn software. Conclusion: Our results represent the first proof-of-concept study of G2-S16/DPV combination to develop a safe microbicide.


Asunto(s)
Fármacos Anti-VIH/farmacología , Dendrímeros/farmacología , Células Epiteliales/efectos de los fármacos , VIH-1/efectos de los fármacos , Pirimidinas/farmacología , Silanos/farmacología , Animales , Fármacos Anti-VIH/administración & dosificación , Fármacos Anti-VIH/toxicidad , Bacterias Anaerobias/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Chlorocebus aethiops , Dendrímeros/administración & dosificación , Dendrímeros/toxicidad , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Células Epiteliales/virología , Infecciones por VIH/prevención & control , Humanos , Pruebas de Sensibilidad Microbiana , Polielectrolitos , Polímeros , Pirimidinas/administración & dosificación , Pirimidinas/toxicidad , Silanos/administración & dosificación , Silanos/toxicidad , Células Vero
13.
Part Fibre Toxicol ; 16(1): 40, 2019 10 29.
Artículo en Inglés | MEDLINE | ID: mdl-31665028

RESUMEN

BACKGROUND: Amorphous silica nanoparticles (SiO2 NPs) have been regarded as relatively benign nanomaterials, however, this widely held opinion has been questioned in recent years by several reports on in vitro and in vivo toxicity. Surface chemistry, more specifically the surface silanol content, has been identified as an important toxicity modulator for SiO2 NPs. Here, quantitative relationships between the silanol content on SiO2 NPs, free radical generation and toxicity have been identified, with the purpose of synthesizing safer-by-design fumed silica nanoparticles. RESULTS: Consistent and statistically significant trends were seen between the total silanol content, cell membrane damage, and cell viability, but not with intracellular reactive oxygen species (ROS), in the macrophages RAW264.7. SiO2 NPs with lower total silanol content exhibited larger adverse cellular effects. The SAEC epithelial cell line did not show any sign of toxicity by any of the nanoparticles. Free radical generation and surface reactivity of these nanoparticles were also influenced by the temperature of combustion and total silanol content. CONCLUSION: Surface silanol content plays an important role in cellular toxicity and surface reactivity, although it might not be the sole factor influencing fumed silica NP toxicity. It was demonstrated that synthesis conditions for SiO2 NPs influence the type and quantity of free radicals, oxidative stress, nanoparticle interaction with the biological milieu they come in contact with, and determine the specific mechanisms of toxicity. We demonstrate here that it is possible to produce much less toxic fumed silicas by modulating the synthesis conditions.


Asunto(s)
Macrófagos/efectos de los fármacos , Nanopartículas/toxicidad , Silanos/toxicidad , Dióxido de Silicio/toxicidad , Animales , Técnicas de Cultivo de Célula , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Membrana Celular/patología , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Macrófagos/metabolismo , Macrófagos/patología , Ratones , Nanopartículas/química , Estrés Oxidativo/efectos de los fármacos , Células RAW 264.7 , Especies Reactivas de Oxígeno , Silanos/química , Dióxido de Silicio/química , Propiedades de Superficie
14.
Environ Pollut ; 255(Pt 2): 113309, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31610510

RESUMEN

Azoles are effective antifungal agents used in both medicine and agriculture. They typically work by inhibiting cytochrome P450 enzymes, primarily CYP51 of the ergosterol biosynthesis pathway, thus damaging the fungal cell membrane. However, apart from their desired antifungal properties, several azoles also exhibit endocrine disrupting properties in mammals, both in vitro and in vivo. Here, we have tested two currently used agricultural azole fungicides, triticonazole and flusilazole, for their in vitro anti-androgenic activity and potential effects on reproductive parameters. Both fungicides showed strong androgen receptor (AR) antagonism and disruption of steroid biosynthesis in vitro. Following gestational exposure to flusilazole (15 or 45 mg/kg bw/day) or triticonazole (150 or 450 mg/kg bw/day) in time-mated Sprague Dawley rats, triticonazole induced shorter male anogenital distance (AGD). Flusilazole exposure did not affect the AGD, but altered fetal male blood hormone profile, with increased androstenedione and decreased estrone levels. Flusilazole and triticonazole have dissimilar effects on reproductive parameters in vivo, but both show endocrine disrupting activities.


Asunto(s)
Ciclopentanos/toxicidad , Disruptores Endocrinos/toxicidad , Fungicidas Industriales/toxicidad , Silanos/toxicidad , Triazoles/toxicidad , Antagonistas de Andrógenos , Androstenodiona , Animales , Antifúngicos , Azoles , Masculino , Ratas , Ratas Sprague-Dawley , Reproducción/efectos de los fármacos
15.
Part Fibre Toxicol ; 16(1): 32, 2019 08 16.
Artículo en Inglés | MEDLINE | ID: mdl-31419990

RESUMEN

BACKGROUND: Silica continues to represent an intriguing topic of fundamental and applied research across various scientific fields, from geology to physics, chemistry, cell biology, and particle toxicology. The pathogenic activity of silica is variable, depending on the physico-chemical features of the particles. In the last 50 years, crystallinity and capacity to generate free radicals have been recognized as relevant features for silica toxicity. The 'surface' also plays an important role in silica toxicity, but this term has often been used in a very general way, without defining which properties of the surface are actually driving toxicity. How the chemical features (e.g., silanols and siloxanes) and configuration of the silica surface can trigger toxic responses remains incompletely understood. MAIN BODY: Recent developments in surface chemistry, cell biology and toxicology provide new avenues to improve our understanding of the molecular mechanisms of the adverse responses to silica particles. New physico-chemical methods can finely characterize and quantify silanols at the surface of silica particles. Advanced computational modelling and atomic force microscopy offer unique opportunities to explore the intimate interactions between silica surface and membrane models or cells. In recent years, interdisciplinary research, using these tools, has built increasing evidence that surface silanols are critical determinants of the interaction between silica particles and biomolecules, membranes, cell systems, or animal models. It also has become clear that silanol configuration, and eventually biological responses, can be affected by impurities within the crystal structure, or coatings covering the particle surface. The discovery of new molecular targets of crystalline as well as amorphous silica particles in the immune system and in epithelial lung cells represents new possible toxicity pathways. Cellular recognition systems that detect specific features of the surface of silica particles have been identified. CONCLUSIONS: Interdisciplinary research bridging surface chemistry to toxicology is progressively solving the puzzling issue of the variable toxicity of silica. Further interdisciplinary research is ongoing to elucidate the intimate mechanisms of silica pathogenicity, to possibly mitigate or reduce surface reactivity.


Asunto(s)
Silanos/química , Silanos/toxicidad , Dióxido de Silicio/química , Dióxido de Silicio/toxicidad , Animales , Apoptosis/efectos de los fármacos , Membrana Celular/efectos de los fármacos , Química Computacional , Células Epiteliales/efectos de los fármacos , Humanos , Inmunidad Innata/efectos de los fármacos , Simulación de Dinámica Molecular , Propiedades de Superficie , Canales Catiónicos TRPV/metabolismo
16.
Int J Pharm ; 562: 51-65, 2019 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-30877030

RESUMEN

Non-viral gene delivery vectors studied in the gene therapy applications are often designed with the cationic nitrogen containing groups necessary for binding and cell release of nucleic acids. Disadvantage is a relatively high toxicity which restricts the in vivo use of such nanoparticles. Here we show, that the 3rd generation carbosilane dendrimers possessing (trimethyl)phosphonium (PMe3) groups on their periphery were able to effectively deliver the functional siRNA into the cells (B14, Cricetulus griseus), release it into the cytosol and finally to achieve up to 40% gene silencing of targeted gene (glyceraldehyde-3-phosphate dehydrogenase (GAPDH)) with the comparable or, in some cases, even better effectivity as their ammonium counterparts. Moreover, such cationic dendrimers show relatively low in vivo toxicity as compared to their ammonium analogues when analyzed by standard fish embryo test (FET) on Danio rerio in vivo model, with LD50 = 6.26 µM after 48 h of incubation. This is more than 10-fold improvement as compared to published values for various other types of cationic dendrimers. We discuss the potential of further increase of the transfection efficiency, endosomal escape and decrease of toxicity of such non-viral vectors, based on the systematic screening of different types of substituents on central phosphonium atom.


Asunto(s)
Dendrímeros/toxicidad , Compuestos Organofosforados/toxicidad , ARN Interferente Pequeño/administración & dosificación , Silanos/toxicidad , Transfección/métodos , Animales , Línea Celular , Cricetulus , Dendrímeros/administración & dosificación , Embrión no Mamífero , Silenciador del Gen , Dosificación Letal Mediana , Compuestos Organofosforados/administración & dosificación , Silanos/administración & dosificación , Pez Cebra
17.
Langmuir ; 35(5): 1495-1502, 2019 02 05.
Artículo en Inglés | MEDLINE | ID: mdl-30089359

RESUMEN

In this paper, a novel kind of zwitterion modified graphene oxide (GO) for promoting stability and reducing aggregation of GO as a drug carrier was proposed and demonstrated. Specifically, the GO was functionalized with a kind of zwitterion based silane, 3-(dimethyl(3-(trimethoxysilyl)propyl)-ammonio)propane-1-sulfonate (SBS). After zwitterion modification, the SBS functionalized GO (GO-SB) shows significantly enhanced stability in both serum-free and serum-containing solution, especially after loading doxorubicin hydrochloride (DOX). According to drug release profiles, the drug-loaded GO-SB exhibits thermosensitive and sustained release behavior. Meanwhile, in vitro studies show that the DOX loaded GO-SB could be easily internalized by HepG2 cells and exhibit obvious cytotoxicity on the cells. And, in vivo studies demonstrate that the GO-SB drug carrier is capable of being taken by the larvae of zebrafish and can be eliminated from the body within several days.


Asunto(s)
Antineoplásicos/farmacología , Doxorrubicina/farmacología , Portadores de Fármacos/química , Grafito/química , Silanos/química , Animales , Portadores de Fármacos/toxicidad , Liberación de Fármacos , Grafito/toxicidad , Células Hep G2 , Humanos , Silanos/toxicidad , Pez Cebra
18.
Nanotoxicology ; 12(8): 797-818, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30182770

RESUMEN

Glycodendrimers (Glyco-DDMs) represent a rapidly growing class of nanoparticles with promising properties for biomedical applications but concerns regarding the impact on human health and environment are still justified. Here we report, for the first time, the comparative study of in vivo developmental toxicity of carbosilane Glyco-DDMs and their cytotoxicity in vitro. Carbosilane Glyco-DDMs (generation 1-3) containing 4, 8, and 16 ß-d-glucopyranosyl units at the periphery (DDM1Glu, DDM2Glu, and DDM3Glu) were synthesized and characterized by 1H, 13C and 29Si NMR, mass spectrometry, dynamic light scattering, atomic force microscopy (AFM), and computer modeling. In vitro cytotoxicity assay (MTT) of DDM1-3Glu was performed on three different rodent cell lines (Cricetulus griseus) - B14 (ATCC, CCL-14.1), BRL 3A (ATCC, CRL-1442), and NRK 52E (ATCC, CRL-1571). Overall, very low cytotoxicity was observed with calculated IC50 in mM range with slight difference between each cell line and DDM generation investigated. Modified fish embryo test (FET) was further used for DDM3Glu developmental toxicity testing on zebrafish (Danio rerio) embryos. While seemingly harmless to intact embryos, adverse effects of DDMs on the embryonic development become evident after chorion removal (LD50=2.78 µM at 96 hpe). We summarized that the modified FET test showed a two to three orders of magnitude difference between the in vitro cytotoxicity and in vivo developmental toxicity of DDM3Glu. While, in general, the Glyco-DDMs show great promises as efficient vectors in targeted drug delivery or as therapeutic molecules itself, we suggest that their developmental toxicity should be thoroughly investigated to exclude safety risks associated with their potential biomedical use.


Asunto(s)
Dendrímeros/toxicidad , Embrión no Mamífero/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Silanos/toxicidad , Teratógenos/toxicidad , Pez Cebra , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Cricetulus , Dendrímeros/química , Glucosa/química , Humanos , Dosificación Letal Mediana , Modelos Moleculares , Silanos/química , Propiedades de Superficie , Teratógenos/química , Pruebas de Toxicidad , Pez Cebra/embriología
19.
Carbohydr Polym ; 199: 193-204, 2018 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-30143120

RESUMEN

In the present study, tosylcellulose (TC) was used as a key intermediate for the selective coupling with 3-aminopropyltrimethoxysilane (APTMS) affording amino-propylsilane-grafted tosylcellulose (TC-Si). Solid state 13C NMR and FT-IR analyses confirmed the coupling and self-condensation of APTMS along TC. The changes in the surface morphology of the functionalized cellulose were identified by SEM imaging. The thermal stability of TC-Si was significantly improved as compared to MCC and TC. A new organic/inorganic hybrid cellulosic material was fabricated by embedding TiO2 nanoparticles into TC-Si network. The new cellulose polymers were investigated for their ability to promote the proliferation of human skin fibroblast (BJ1). The cell cytotoxicity assay showed that both TC and TC-Si possessed moderate toxicity to BJ1 cells by 17% and 23.8%, respectively at 20 µM. Meanwhile, TC-Si/TiO2 hybrid enhanced the proliferation of BJ1 by 42%. Additionally TC-Si/TiO2 hybrid demonstrated promising antimicrobial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans.


Asunto(s)
Antiinfecciosos/farmacología , Proliferación Celular/efectos de los fármacos , Celulosa/análogos & derivados , Fibroblastos/efectos de los fármacos , Propilaminas/farmacología , Silanos/farmacología , Titanio/farmacología , Antibacterianos/síntesis química , Antibacterianos/química , Antibacterianos/farmacología , Antibacterianos/toxicidad , Antiinfecciosos/síntesis química , Antiinfecciosos/química , Antiinfecciosos/toxicidad , Antifúngicos/síntesis química , Antifúngicos/química , Antifúngicos/farmacología , Antifúngicos/toxicidad , Materiales Biocompatibles/síntesis química , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Materiales Biocompatibles/toxicidad , Candida albicans/efectos de los fármacos , Línea Celular , Celulosa/síntesis química , Celulosa/farmacología , Celulosa/toxicidad , Humanos , Nanopartículas/química , Nanopartículas/toxicidad , Porosidad , Propilaminas/química , Propilaminas/toxicidad , Pseudomonas aeruginosa/efectos de los fármacos , Silanos/química , Silanos/toxicidad , Staphylococcus aureus/efectos de los fármacos , Andamios del Tejido/química , Titanio/química , Titanio/toxicidad
20.
Regul Toxicol Pharmacol ; 98: 209-214, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30056248

RESUMEN

In the context of a larger testing programme that aimed at assessing the skin sensitisation potential of functional polysiloxanes and silanes, this investigation complements the available in vitro and in vivo data with data in the SENS-IS assay, a human in vitro 3D skin-based model. The SENS-IS assay allowed testing of all functional polysiloxanes and silanes without any solubility issues or limitations related to the multiconstituent nature of the commercial grade test substances. It appeared to encompass skin metabolism, a factor which we considered important for the skin sensitisation hazard assessment particularly of aminofunctionalised siloxanes and silanes. These three technical aspects posed significant challenges in the first part of the in vitro programme with the OECD-validated in vitro assays. The SENS-IS assay delivered promising results for this group of substances. On its own, it was the best performing model, as it did not pose any technical issues with the assay and it matched all in vivo outcomes. Considering its performance and avoidance of any limitations due to lack of solubility or chemical composition aspects, we concluded that the SENS-IS assay to be a suitable starting point for an integrated testing strategy for skin sensitisation for the group of functional polysiloxanes and silanes.


Asunto(s)
Alérgenos/toxicidad , Bioensayo , Haptenos/toxicidad , Irritantes/toxicidad , Silanos/toxicidad , Siloxanos/toxicidad , Dermatitis Alérgica por Contacto , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...